EnCor Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- EnCor Biotechnology's estimated annual revenue is currently $1.1M per year.
- EnCor Biotechnology's estimated revenue per employee is $155,000
Employee Data
- EnCor Biotechnology has 7 Employees.
- EnCor Biotechnology grew their employee count by 0% last year.
EnCor Biotechnology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
EnCor Biotechnology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15.3M | 99 | 5% | N/A | N/A |
#2 | $1.1M | 7 | -30% | N/A | N/A |
#3 | $3.7M | 24 | 4% | N/A | N/A |
#4 | $4.3M | 28 | -3% | N/A | N/A |
#5 | $2.5M | 16 | N/A | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $2.5M | 16 | 7% | N/A | N/A |
#9 | $1.4M | 9 | -25% | N/A | N/A |
#10 | $0.6M | 4 | 0% | N/A | N/A |
What Is EnCor Biotechnology?
EnCor grew out of the research activities of Dr. Gerry Shaw, a Professor at the University of Florida, formerly of the Max Planck Institute of Biophysical Chemistry in Goettingen, Germany. The company originally produced antibodies generated in Dr. Shaw's research laboratory and now independently develops novel immunoreagents on a routine basis.
keywords:N/A
N/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Gainesville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 7 | 0% | N/A |
#2 | $0.5M | 7 | N/A | N/A |
#3 | $0.5M | 7 | -12% | N/A |
#4 | $0.5M | 7 | 0% | N/A |
#5 | $0.7M | 7 | 0% | N/A |